XNAS · LITS
+1.65% · +$0.0161 · Vol 78.0K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Lite Strategy, Inc. Common Stock

Lite Strategy, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.9930
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is LITS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for LITS are being assembled.
About Lite Strategy, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2003
Employees
4
Country
US

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.9800
Day high
$1.00
Day low
$0.9783
Previous close
$0.9769
52W high
$1.00
-1.04% from high
52W low
$0.6998
97% of range
Market cap
$33.2M
EPS
$-2.1333
Shares out
34M
Volume
78K
VWAP
$0.9922
Price history computed in-house
1W
-0.50%
1M
+41.90%
SMA 50 $0.8908 · above
SMA 200 $0.8908 · above
52W position 97%
Veridion warehouse edge

Warehouse intelligence for LITS.

Veridion Score
40
0: 501: 402: 423: 504: 295: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

LITS insider activity

Lite Strategy, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for LITS.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

LITS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LITS in this window.
Lobbying spend

LITS lobbying filings, year to date.

Registered lobbying filings matched to Lite Strategy, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LITS in this window.
Latest news · LITS
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for LITS.
Options
Sovereign unlock shows live options positioning for LITS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.